UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute UC San Diego Shiley Eye Institute
by name
Afshari, Natalie A. Brown, Stuart I. Chao, Daniel L. Ferrara, Napoleone Ferreyra, Henry A. Freeman, William R. Goldbaum, Michael H. Granet, David B. Haw, Weldon W. Heichel, Chris W. Kikkawa, Don O. Korn, Bobby S. Lee, Jeffrey E. Lin, Jonathan H. Nguyen, Thao P. Nudleman, Eric Robbins, Shira L. Savino, Peter J. Slight, Rigby Weinreb, Robert N. Welsbie, Derek S. Zhang, Kang
by specialty
Comprehensive Ophthalmology Cornea & Refractive Surgery Glaucoma Neuro-Ophthalmology Ophthalmic Genetics Ophthalmic Pathology Ophthalmic Plastic & Reconstructive Surgery Optometry & Low Vision Pediatric Ophthalmology & Eye Alignment Disorders Refractive Surgery / LASIK Retina & Vitreous Thyroid Eye Clinic
by condition
AMD (Age-related Macular Degeneration) Cataracts Corneal Conditions Cosmetic Surgery Diabetic Retinopathy Eye Movement Disorders Glaucoma Hereditary (Genetic) Disorders Low Vision Neuro-Ophthalmic Conditions Ophthalmic Plastic and Reconstructive Surgery Pediatric Conditions Refractive Errors Retinal Diseases Thyroid Eye Disease

Visual Field Reading Center

VisFACT Visual Field Reading Center

Who We Are

The Visual Field Assessment Center (VisFACT), a visual field reading center, offers a wide variety of services in support of clinical research. Our highly skilled researchers and staff are expertly trained in several types of visual field testing and analysis. Our extensive experience includes collaboration with pharmaceutical companies, other universities, research centers, and clinics in the United States and around the world.

What We Do
Our areas of expertise include, but are not limited to, the Humphrey Field Analyzer and Frequency Doubling Technology Perimetry. We often work directly with the manufacturers and engineers of our visual field equipment and related software. 

Services
VisFACT offers a variety of services to meet study-specific needs. Dr. Bowd and the VisFACT team will work with the study sponsor to provide the optimum complement of services to ensure successful data extraction, management, and quality of visual fields.

Protocol Development

  • Assist in development of visual field protocols
  • Develop and maintain data collection forms and study documents
  • Provide study-specific manual of procedures
  • Provide protocols and training for electronic transfer of visual fields between sites and sponsors.
  • Provide study-specific information to study manufacturers to assist in upgrading or standardizing instruments across sites

Training and Certification

  • Training of study personnel
  • Certification of study personnel

Quality Assessment

  • Review visual fields for quality and adherence to protocol
  • Provide quality control feedback to study centers
  • Request repeated testing or data corrections as needed to ensure complete and accurate data
  • Test and pre-approve all instrument hardware and software upgrades utilized

Data Handling  

  • FDA, HIPAA and IRB compliant data handling
  • Study-specific visual field quality and protocol adherence assessment
  • In-house IT /computer programming specialists available to create and maintain secure databases and provide support for all study needs
  • Efficient electronic transfer of visual fields and test results

Processing and Analysis 

  • Review visual fields for specific diagnoses and inclusion/exclusion criteria
  • Provide progression analysis
  • Provide statistical analysis
  • Other Services
  • Contact Dr. Bowd to discuss services not listed above
  • A companion reading center, the IDEA Center, is available to provide similar services for photographic and imaging data.

Reading Center Studies

VisFACT has provided reading center services for the following studies:
Sponsored by National Eye Institute:

  • Diagnostic Innovations in Glaucoma Study (DIGS) (1995-2016)
  • Diagnostic Innovations in Glaucoma: Clinical Electrophysiology (2007-2009)
  • African Descent and Glaucoma Evaluation Study (ADAGES) (2002-2016)
  • Medical Advice from Glaucoma Informatics (MAGI)  (2002-2007)
  • Predicting and Detecting Glaucomatous Progression Using Pattern Recognition (2012-2016)

Sponsored by Catalyst Pharmaceutical Partners  (2010-2013)

  • Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study. Protocol Number CPP-01005.
  • Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study. Protocol Number CPP-01004.
  • Vigabatrin for Treatment of Methamphetamine Dependence:
  • A Phase II Study. Number CPP-02001.

Reading Center Personnel
Linda Zangwill, PhD; Director, IDEA Center
Christopher Bowd, PhD; Director, VisFACT
Keri Dirkes, MPH; Supervisor, IDEA Center/ VisFACT
Maria Hunsicker; Coordinator, IDEA Center
Suzanne Vega, MPH; Coordinator, VisFACT/ IDEA Center

Scientific Advisory Board of our Reading Centers includes internationally recognized ophthalmologists and researchers including:
Christopher Bowd, PhD
Robert N. Weinreb, MD
Linda M. Zangwill, PhD

 

K12 Award Program

The overall objective of the NEI Mentored Clinical Scientist Development Program Award at UCSD is to develop outstanding clinician scientists to successfully compete at the national level for NIH grants and emerge as leaders within academic Ophthalmology. Through this institutional career development award, we will mentor clinician scientists toward independent academic appointments in ophthalmology.

VIEW MORE

In the News

Lions Club Gives $400,000 for BioBank

Specialized Care for Dry Eyes

Possible Answer to Dry Eye?

Advocacy Ambassadors for this year’s American Academy of Ophthalmology’s (AAO) Mid-Year Forum

Goldbaum Celebrates 40 Years

VIEW MORE

Whats Your Symptom Disclaimer

The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.

The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.

The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.

Click Here To Accept

Email Us

First Name*
Last Name*
Email*
Phone
MRN
Topic

Required *

Submit